Riken Vitamin Co., Ltd. (4526.T) JPX

Currency In JPY

AD

Valuation

Market Cap88.26B
Enterprise Value88.26B
P/E Ratio14.78
PEG Ratio-0.83
Price/Sales Ratio1.05
Price/Book Ratio1.23
Enterprise/Revenue0.95
Enterprise/EBITDA7.82

Fiscal Year

Fiscal YearJune 19, 2026
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.07
Operating Margin0.07
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.09

Income Statement

Revenue0
Revenue/Share3,369.44
Gross Profit-29.77B
EBITDA3B
Net Income0
Diluted EPS0

Balance Sheet

Total Cash17.91B
Total Cash/Share614.51
Total Debt7.4B
Total Debt/Equity0.09
Current Ratio3.51
Book Value Per Share2,896.67

Price History

52-Week Change25.4
52-Week High3,750
52-Week Low2,662
Moving Average 50 Days3,302.1
Moving Average 200 Days3,080.75

Statistics

Average Volume94,653
Shares Outstanding29.03M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate110
Trailing Annual Dividend Yield3.09
Payout Ratio0
Last Split Factor2:1
Last Split DateMarch 30, 2020
AD